APA

Metra M., Eichhorn E., Abraham W. T., Linseman J., Böhm M., Corbalan R., DeMets D., De Marco T., Elkayam U., Gerber M., Komajda M., Liu P., Mareev V., Perrone S. V., Poole-Wilson P., Roecker E., Stewart J., Swedberg K., Tendera M., Wiens B. & Bristow M. R. (20110111). Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials. : European heart journal.

Chicago

Metra Marco, Eichhorn Eric, Abraham William T, Linseman Jennifer, Böhm Michael, Corbalan Ramon, DeMets David, De Marco Teresa, Elkayam Uri, Gerber Michael, Komajda Michel, Liu Peter, Mareev Vyacheslev, Perrone Sergio V, Poole-Wilson Philip, Roecker Ellen, Stewart Jennifer, Swedberg Karl, Tendera Michal, Wiens Brian and Bristow Michael R. 20110111. Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials. : European heart journal.

Harvard

Metra M., Eichhorn E., Abraham W. T., Linseman J., Böhm M., Corbalan R., DeMets D., De Marco T., Elkayam U., Gerber M., Komajda M., Liu P., Mareev V., Perrone S. V., Poole-Wilson P., Roecker E., Stewart J., Swedberg K., Tendera M., Wiens B. and Bristow M. R. (20110111). Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials. : European heart journal.

MLA

Metra Marco, Eichhorn Eric, Abraham William T, Linseman Jennifer, Böhm Michael, Corbalan Ramon, DeMets David, De Marco Teresa, Elkayam Uri, Gerber Michael, Komajda Michel, Liu Peter, Mareev Vyacheslev, Perrone Sergio V, Poole-Wilson Philip, Roecker Ellen, Stewart Jennifer, Swedberg Karl, Tendera Michal, Wiens Brian and Bristow Michael R. Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials. : European heart journal. 20110111.